- Home
- TLS vs ZVRA Comparison
TLS vs ZVRA Comparison
Compare TLS & ZVRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TLS
- ZVRA
- Stock Information
- Founded
- TLS 1969
- ZVRA 2006
- Country
- TLS United States
- ZVRA United States
- Employees
- TLS N/A
- ZVRA N/A
- Industry
- TLS EDP Services
- ZVRA Biotechnology: Pharmaceutical Preparations
- Sector
- TLS Technology
- ZVRA Health Care
- Exchange
- TLS Nasdaq
- ZVRA Nasdaq
- Market Cap
- TLS 496.6M
- ZVRA 467.6M
- IPO Year
- TLS 2020
- ZVRA 2015
- Fundamental
- Price
- TLS $6.71
- ZVRA $10.07
- Analyst Decision
- TLS Hold
- ZVRA Strong Buy
- Analyst Count
- TLS 4
- ZVRA 7
- Target Price
- TLS $5.83
- ZVRA $22.57
- AVG Volume (30 Days)
- TLS 759.4K
- ZVRA 1.7M
- Earning Date
- TLS 11-10-2025
- ZVRA 11-05-2025
- Dividend Yield
- TLS N/A
- ZVRA N/A
- EPS Growth
- TLS N/A
- ZVRA N/A
- EPS
- TLS N/A
- ZVRA N/A
- Revenue
- TLS $116,739,000.00
- ZVRA $62,020,000.00
- Revenue This Year
- TLS $47.80
- ZVRA $336.43
- Revenue Next Year
- TLS $26.19
- ZVRA $54.26
- P/E Ratio
- TLS N/A
- ZVRA N/A
- Revenue Growth
- TLS N/A
- ZVRA 161.81
- 52 Week Low
- TLS $1.83
- ZVRA $6.19
- 52 Week High
- TLS $7.72
- ZVRA $13.16
- Technical
- Relative Strength Index (RSI)
- TLS 46.27
- ZVRA 47.13
- Support Level
- TLS $6.38
- ZVRA $9.67
- Resistance Level
- TLS $7.72
- ZVRA $11.23
- Average True Range (ATR)
- TLS 0.36
- ZVRA 0.53
- MACD
- TLS -0.09
- ZVRA -0.16
- Stochastic Oscillator
- TLS 24.58
- ZVRA 24.18
About TLS Telos Corporation
Telos Corp offers technologically forwarded, software-based security solutions that empower and protect the world's security-conscious organizations against rapidly evolving, sophisticated, and pervasive threats. Its business has two reportable and operating segments namely Security Solutions and Secure Networks. The Security Solutions segment focuses on cybersecurity, cloud, and identity solutions, and the Secure Networks focuses on enterprise security. The company derives maximum revenue from the Security Solutions segment.
About ZVRA Zevra Therapeutics Inc.
Zevra Therapeutics Inc is a rare disease company combining science, data, and patient needs to create transformational therapies for diseases with limited or no treatment options. The company's mission is to bring life-changing therapeutics to people living with rare diseases. With data-driven development and commercialization strategies, it is overcoming complex drug development challenges to make new therapies available to the rare disease community.